The call for real-world evidence is the “shot heard round the world” in this new decade of global healthcare. Skyrocketing healthcare costs, an unraveling state of global finance and unprecedented technological advances in medicine have both commercial and government payers looking for answers to what seems to be an age-old question: How do we reduce costs while improving quality?
Elsevier Business Intelligence invites you to Market Access in the Era of Specialty & Biotech – An EBI Virtual Conference, in partnership with inVentiv Health. On December 13, attendees will hear insights from market access and regulatory thought leaders at inVentiv Patient Access Solutions, Health Policy Strategies, Prevision Policy, ParagonRx, PharmaNet/i3, and Campbell Alliance. Gather information on tactics and best practices from experts at ZIOPHARM Oncology, Shire and Novo Nordisk. Learn what payers and government policymakers are focused on in the coming years, with representation from inVentiv Medical Management, Mayo Clinic, MedMetrics and the Agency for Healthcare Research and Quality.Date: December 13, 2011
Time: 10:00 am – 4:30pm ET
Duration: 6 hours & 30 minutes
Time: 10:00 am – 4:30pm ET
Duration: 6 hours & 30 minutes